Atricure Stock Investor Sentiment

ATRC Stock  USD 36.17  0.38  1.06%   
About 57% of AtriCure's investor base is looking to short. The analysis of overall sentiment of trading AtriCure stock suggests that many investors are alarmed at this time. The current market sentiment, together with AtriCure's historical and current headlines, can help investors time the market. In addition, many technical investors use AtriCure stock news signals to limit their universe of possible portfolio assets.
  

AtriCure Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards AtriCure can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
18 hours ago at finance.yahoo.com         
AtriCure, Inc. Shares Could Be 26 percent Below Their Intrinsic Value Estimate
Yahoo News
over a week ago at finance.yahoo.com         
AtriCure to Participate in the Piper Sandler 36th Annual Healthcare Conference
Yahoo News
over a week ago at news.google.com         
AtriCure, Inc. Receives 43.11 Average Price Target from Brokerages - MarketBeat
Google News at Macroaxis
over a week ago at www.macroaxis.com         
Disposition of 4417 shares by Dahlquist Karl S. of AtriCure at 44.83 subject to Rule 16b-3
Macroaxis News
over a week ago at businesswire.com         
VentureOne de ATRC lanza QuantumGate para resguardar datos para la era cuntica en CyberQ
businesswire News
over a week ago at businesswire.com         
VentureOne da ATRC lana a QuantumGate para a proteo dos dados na era quntica na CyberQ
businesswire News
over a week ago at businesswire.com         
VentureOne, oddzia ATRC, prezentuje QuantumGate rozwizanie do zabezpieczania danych na potrzeby ery ...
businesswire News
over a week ago at businesswire.com         
VentureOne di ATRC lancia QuantumGate per proteggere i dati al Quantum Era del CyberQ
businesswire News
over a week ago at businesswire.com         
ATRCs VentureOne lanceert QuantumGate om gegevens te beveiligen voor het kwantumtijdperk tijdens Cyb...
businesswire News
over a week ago at businesswire.com         
Az ATRC VentureOne a kvantumkorszak adatbiztonsgnak rdekben elindtja a QuantumGate-et a CyberQ-nl
businesswire News
over a week ago at businesswire.com         
Spolenost VentureOne ze skupiny ATRC pedstavuje na veletrhu CyberQ projekt QuantumGate pro zabezpeen...
businesswire News
over two weeks ago at businesswire.com         
ATRCs VentureOne Launches QuantumGate to Secure Data for the Quantum Era at CyberQ
businesswire News
over two weeks ago at gurufocus.com         
AtriCure Inc Stock Price Down 3.06 percent on Nov 12
Gurufocus Stories at Macroaxis
over two weeks ago at finance.yahoo.com         
AtriCure to Participate in the Stifel 2024 Healthcare Conference
Yahoo News
over two weeks ago at thelincolnianonline.com         
Perkins Capital Management Inc. Sells 500 Shares of AtriCure, Inc.
news
Far too much social signal, news, headlines, and media speculation about AtriCure that are available to investors today. That information is available publicly through AtriCure media outlets and privately through word of mouth or via AtriCure internal channels. However, regardless of the origin, that massive amount of AtriCure data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of AtriCure news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of AtriCure relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to AtriCure's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive AtriCure alpha.

AtriCure Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Is It Time To Consider Buying AtriCure, Inc.
09/16/2024
2
AtriCure Announces Launch of cryoSPHERE MAX Probe for Post-Operative Pain Management
10/15/2024
3
AtriCure plans a surgical pulsed field ablation play
10/30/2024
4
AtriCure Hits 80-Plus Relative Strength Rating Benchmark
10/31/2024
5
A Piece Of The Puzzle Missing From AtriCure, Inc.s 28 percent Share Price Climb
11/06/2024
6
AtriCure to Participate in the Stifel 2024 Healthcare Conference
11/07/2024
7
Spolenost VentureOne ze skupiny ATRC pedstavuje na veletrhu CyberQ projekt QuantumGate pro zabezpeen dat pro kvantovou ru
11/14/2024
8
Disposition of 4417 shares by Dahlquist Karl S. of AtriCure at 44.83 subject to Rule 16b-3
11/15/2024
9
AtriCure to Participate in the Piper Sandler 36th Annual Healthcare Conference
11/20/2024

Complementary Tools for AtriCure Stock analysis

When running AtriCure's price analysis, check to measure AtriCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AtriCure is operating at the current time. Most of AtriCure's value examination focuses on studying past and present price action to predict the probability of AtriCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AtriCure's price. Additionally, you may evaluate how the addition of AtriCure to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Stocks Directory
Find actively traded stocks across global markets
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences